PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
1.90 - 2.15
0.48 - 2.54
9.88M / 3.06M (Avg.)
-0.59 | -3.40
These metrics indicate whether the stock trades cheaply or expensively relative to its fundamentals. Value investors use them to find mispricings—buying stocks that appear undervalued, with solid long-term prospects and limited downside risk.
-100.24
Negative P/E while Healthcare median is -4.86. Seth Klarman would scrutinize path to profitability versus peers.
14.12
P/S near Healthcare median of 15.69. Charlie Munger would examine if similar pricing reflects similar economics.
1.13
P/B less than half the Healthcare median of 3.80. Joel Greenblatt would investigate if assets are truly impaired. Check ROE versus peers.
-23.58
Negative FCF while Healthcare median P/FCF is -23.44. Seth Klarman would investigate cash flow improvement potential.
-29.46
Negative operating cash flow while Healthcare median P/OCF is -19.83. Seth Klarman would investigate operational improvement potential.
1.13
Fair value ratio less than half the Healthcare median of 3.81. Joel Greenblatt would investigate if this discount is justified.
-0.25%
Negative earnings while Healthcare median yield is -0.65%. Seth Klarman would investigate path to profitability.
-4.24%
Negative FCF while Healthcare median yield is -0.60%. Seth Klarman would investigate cash flow improvement potential.